Литература к главе 4

965. Agarwal D. P., Goedde H. W. (1984). Alkoholmetabolisierende Enzyme: Alkoholunvertraglichkeit und Alkoholkrankheit. In: Zang K. D. (ed.), Klinische Genetik des Alkoholismus, Verlag W. Kohlhammer, Stuttgart, pp. 65-89.

966. Alter B. P. (1985). Antenatal diagnosis of thalassemia: a review, Ann. NY Acad. Sci., 445, 393-407.

967. Alter B. P., Nathan D. G. (1978). Antenatal diagnosis of haematological disorders - "1978", Clin. Haematol., 7, 195-216.

968. Amara S. G., Jonas V., Rosenfeld M. G., Ong E. S., Evans R. M. (1982). Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products, Nature, 298, 240-244.

968a. Amrheim J. A., Meyer W. J. III, Jones H. W., Migeon C. J. (1976). Androgen insensitivity in man: Evidence for genetic heterogeneity, Proc. Natl. Acad. Sci. USA, 73, 891-894.

969. Anonymous (1973). Pharmacogenetics, Report of a WHO scientific group, WHO technical Report Series N, 524, Geneva.

970. Anonymous (1978). Editorial: Fetal haemoglobin in sickle-cell anaemia and thalassemia - a clue to therapy? Lancet, 1, 971-972.

971. Anonymous (1984). Report on the Workshop "Molecular Basis of Polymorphic Drug Oxidation in Man", Otzenhausen, 1983, Eur. J. Clin. Pharmacol., 27, 253-257.

972. Antonarakis S. E., Kazazian H. H., Jr., Orkin S. H. (1985). DNA polymorphism and molecular pathology of the human globin gene clusters, Hum. Genet., 69, 1-14.

973. Anton-Lamprecht I., Schnyder U. W. (1974). Ultrastructure of inborn errors of keratinization. VI. Inherited ichthyoses - a model system for heterogeneities in Keratinization disturbances, Arch. Dermatol. Forsch., 250, 207-227.

974. Anton-Lamprecht I., Hashimoto I. (1976). Epidermolysis bullosa dystrophica dominans (Pasini) - A primary structural defect of the anchoring fibrils, Hum. Genet., 32, 69-76.

975. Atlas S. A., Vesell E. S., Nebert D. W. (1976). Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes, Cancer Res., 36, 4619.

976. Ayesh R., Idle J.R., Ritchie J. C., Crothers M.J., Hetzel M. R. (1984). Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature, 312, 169-170.

977. Bach G., Friedman R., Weissman В., Neufeld E. F. (1972). The defect in the Hurler and Scheie syndromes: deficiency of α-L-iduronidase, Proc. Natl. Acad. Sci. USA, 69, 2048.

978. Bangham A. D. (1968). Membrane models with phospholipids, Progr. Biophys., 18, 29-95.

979. Bank A. (1978). Critical review. The thalassemia syndromes, Blood, 51, 369-384.

980. Bank A., Mears J. G., Ramirez F. (1979). Organization of the human globin genes in normal and thalassemia cells. In: Stamatoyannopoulos G., Nienhuis A. (eds.), Cellular and molecular regulation of hemoglobin switching, Grune and Stratton, New York, pp. 521-539.

981. Baralle F. E., Shoulders С. С., Proudfoot N. J. (1980). The primary structure of the human epsilonglobin gene, Cell, 21, 621-626.

982. Barranger J. A. (1984). Marrow transplantation in genetic disease, N. Engl. J. Med., 311, 1629-1631.

983. Bartoldi F., Giovenco S., Sostia W., Maiconi W., Morisi F., Pittalis F., Prospen G., Spotorno G. (1977). Biomedical application of fibre entrapped enzymes, Pharmacol. Res. Comm., 9, 521-546.

984. Bartholome K., Lutz P., Bickel H. (1975). Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia, Pediatr. Res., 9, 899-903.

985. Bauknecht T. (1977). Studies on steroid hormone receptors (5α-Dihydrotestosterone, Estradiol, and Dexamethasone) in cultured human fibroblasts and amniotic fluid cells, Hum. Genet., 39, 321-328.

986. Beadle G. W. (1945). Biochemical genetics, Chem. Rev., 37, 15-96.

987. Beadle G. W., Ephrussi B. (1936). The differentiation of eye pigment in drosophila as studied by transplantations, Genetics, 21, 225-247.

988. Beadle G. W., Tatum E. L. (1941). Genetic control of biochemical reactions in neurospora, Proc. Natl. Acad. Sci. USA, 27, 499-506.

989. Beauchamp G. K., Yamazaki K., Boyse E. A. (1985). The chemosensory recognition of genetic individuality, Sci. Am., 253, 86-92.

990. Becker M. A., Kostel P.J., Meyer L.J., Seegmiller J. E. (1973). Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family witch gout and excessive purine synthesis, Proc. Natl. Acad. Sci. USA, 70, 2749.

991. Beet E. A. (1949). The genetics of the sickle cell trait in a Bantu tribe, Ann. Eugen, 14, 279.

992. Bellingham A. J. (1976). Haemoglobins with altered oxygen affinity, Br. Med. Bull., 32, 234-238.

993. Benohr H. Chr., Waller H. D. (1973). Eigenschaften der Glutathionreductase von Erythrocyten Gesunder und Enzymmangeltrager, Klin. Wochenschr., 51, 1177.

994. Benohr H. C., Waller H. D. (1975). Metabolism in haemolytic states, Clin. Haematol., 4, 45-62.

995. Bercroft D. M., Phillips L. I. (1965). Hereditary orotic aciduria and megaloblastic anemia: A second case with response to uridine, Br. Med. J., 1, 547.

996. Betke K., Beutler K., Brewer G. J., Kirkman H. N., Luzzato L., Motulsky A. G., Rcanot В., Siniscalco M. (1967). Standardization of procedures for the study of glucose-6-phosphate dehydrogenase, WHO Tech. Rep. Ser., No 366.

997. Beutler E. (1969). Glutathione reductase stimulation in normal subjects by ribiflavin supplementation, J. Clin. Invest., 48, 1957.

998. Beutler E. (1969). Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies, J. Clin. Invest., 48, 1957-1966.

999. Beutler E. (1969). G-6-PD activity of individual erythrocytes and X-chromosomal inactivation. In: Yunis J. J. (ed.), Biochemical methods in red cell genetics, Academic Press, New York, pp. 95-113.

1000. Beutler E. (1975). Red cell metabolism. A manual of biochemical methods, Grune and Stratton, New York, London.

1001. Beutler E. (1978). Hemolytic anemia in disorders of red cell metabolism, Plenum, New York, London.

1002. Beutler E. (1983). Glucose-6-phosphate dehydrogenase deficiency. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S., Goldstein J., Brown M. (eds.), The metabolic basis of inherited disease, 5th ed., McGraw-Hill, New York, pp. 1629-1653.

1003. Beutler E. (1979). Review: Red cell enzyme defects as nondiseases and as diseases, Blood, 54, 1-7.

1004. Bickel H. (1953). Influence of phenylalanine intake on phenylketonuria, Lancet, II, 812.

1005. Bienzle U. (1981). Glucole-6-phosphate dehydrogenase deficiency, Clin. Haematol., 10, 785-799.

1006. Bird A. P. (1984). DNA methylation - how important in gene control? Nature, 307, 503-504.

1007. Blomback M., Blomback В., Mammen E. F., Prasad A. S. (1968). Fibrinogen Detroit - a molecular defect in the N-terminal disulphide knot of human fibrinogen? Nature, 218, 134.

1008. Blyumina M. G. (1981). Blood serum phenylalanine level in heterozygotes for the phenylketonuria gene under conditions of intensified protein catabolism, Genetika (Moskva), 17, 910-914.

1009. Boivin P., Gerland С (1965). La synthese du glutathion au cours de l'anemie hemolytique congenitale avec deficit en glutathion reduit, Deficit congenital en glutathion-synthetase erytrocytaire? Nouv. Rev. Er. Hematol., 5, 606.

1010. Borthwell Т. Н., Charlton R. W., Motulsky A. G. (1983). Idiopathic hemochromatosis. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S., Goldstein J. L., Brown M. S. (eds.), The Metabolic Basis of Inherited Disease, 5th Ed., McGraw-Hill, New York, pp. 1269-1298.

1011. Boue J., Bom A., Philippe E., Giraud A., Deluchat C. (1973). Phenotypes of karyotyped abortuses, Bull. Eur. Soc. Hum. Genet., 32.

1012. Boyer S. H., Dover G. J., Serjeant G. R., Smith K. D., Antonarakis S. E., Embury S. H., Margolet L., Noyes A. N., Boyer M. L., Bias W.B. (1984). Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the P-globin gene cluster, Blood, 64, 1053-1058.

1013. Boyer S. H., Rucknagel D. L., Weatherall D. J., Watson-Williams E. J. (1963). Further evident for linkage between the β and δ loci governing human hemoglobins and the population dynamics of linked genes, Am. J. Hum. Genet., 15, 438-448.

1014. Bradley Т. В., Boyer S. H., Allen F. H. (1961). Hopkins-2-hemoglobin: a revised pedigree with data on blood and serum groups, Bull. Johns Hopkins Hosp., 108, 75-79.

1015. Brady R. D., Koloday E. H. (1973). Disorders of ganglioside metabolism, ProG. Med. Genet., 8, 225-242.

1016. Braunitzer G., Hilschmann N., RudloffV., Hilse K., Liebold В., Muller R. (1961). The haemoglobin particles. Chemical and genetic aspects of their structure, Nature, 190, 480.

1017. Brewer G. J. (1971). Annotation: Human ecology, an expanding role for the human geneticist. Am. J. Hum. Genet., 23, 92-94.

1018. Brewer G. J. (1980). Inherited erythrocyte metabolic and membrane disorders, Med. Clin. North America, 64, 579-596.

1019. Britten R. J., Davidson E.H. (1969). Gene regulation for higher cells. A theory, Science, 165, 349-357.

1020. Bross K., Dittes H., Krone W., Schmid M., Vogel W. (1973). Biochemical and cytogenetic studies on the nucleolus organizing regions (NOR) of man. I. Comparison of trisomy 21 with balanced translocations t(DqGq), Hum. Genet., 20, 223-229.

1021. Bross K., Krone W. (1972). On the number of ribosomal RNA genes in man, Hum. Genet., 14, 137.

1022. Bross K., Krone W (1973). Ribosomal cistrons and acrocentric chromosomes in man, Hum. Genet, 18, 71-75.

1023. Brown M. S., Goldstein J. L. (1974). Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man, Science, 185, 61-63.

1024. Buckley R. H., Gilbertsen R. B., Schiff R. I., Ferreira E., Sanal S. O., Waldmann T. A. (1976). Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency: evidence against a stem cell defect, J. Clin. Invest., 58, 130-136.

1025. Burke B. E., Shotton D. M. (1983). Erythrocyte J. Haematol., 54, 173- 187.

1026. Burki K., Liebelt A. G., Bresnick E. (1975). Simple vs. complex inheritance of inducible aryl hydrocarbon hydroxylase in mouse tissues, Biochem. Genet., 13, 417-433.

1027. Butenandt A. (1953). Biochemie der Gene und Genwirkungen, Naturwissenschaften, 40, 91-100.

1028. Butterflield D. A., Chesnut D.B., Roses D., Appel S. H. (1974). Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy, Proc. Natl. Acad. Sci. USA, 71, 909-913.

1029. Cantz M., Gehler J. (1976). The mucopolysaccharidoses: Inborn errors of glycosaminoglycan catabolism, Hum. Genet., 32, 233-255.

1030. Carson P. E., Flanagan C. L., Ickes C. E., Alving A. S. (1956). Enzymatic deficiency in primaquine-sensitive erythrocytes, Science, 124, 484-485.

1031. Cassimos C., Malaka-Zejiriu K., Tsiures J. (1974). Variations in salycilamide glucuronide formation in normal and in G-6-PD deficient children, J. Pediatr., 84, 110-111.

1032. Chandley A. C. (1981). The chromosomal basis of human infertility, Brit. Med. Bull., 35. 181-186.

1033. Chakravarti A., Buetow K. H., Antonarakis S. E., Waber P. G., Boehm C. D., Kazazian H.H. (1984). Nonuniform recombination within the human β-globin cluster, Am. J. Hum. Genet., 36, 1239-1258.

1034. Childs В., Zinkham W. (1958). A genetic study of a defect in glutathione metabolism of the erythrocyte, Johns Hopkins Med. J., 102, 21-37.

1035. Cleaver J. E. (1972). Xeroderma pigmentosum: Variants with normal DNA repair and normal sensitivity to ultraviolet light, J. Invest. Dermatol., 58, 124-128.

1036. Cleaver J. E., Bootsma D.(1975). Xeroderma Pigmentosum: Biochemical and Genetic Characteristics, Ann. Rev. Genet, 9, 19-38

1037. Clegg J. В., Weather all D. J. (1976). Molecular basis of thalassaemia, Br. Med. Bull., 32, 262-269.

1038. Cleve H. (1981). H.-Y. antigen and sex determination. The Tenth Arne Tiselius Memorial lecture. In: Peeters H. (ed.), Protides of the biological fluids, Vol. 29, Pergamon Press, Oxford, New York, pp. 3-12.

1039. Cohen A. S. (1972). Inherited systemic amyloidosis. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), The metabolic basis of inherited disease, 3rd ed., McGraw-Hill, New York, pp. 1273-1294.

1040. Collins F. S., M ether all J. E., Yamakawa M., Pan J., Weissman S. M., Forget B. G. (1985). A point mutation in the Ayglobin gene promoter in Greek hereditary persistence of fetal haemoglobin, Nature, 313, 325-326.

1041. Collins F.S., Weissman S.M. (1984). The Molecular Genetics of Human Hemoglobins, Proc. Nucleic Acid Res. Mol. Biol., 31, 315-462.

1042. Comings D. E. (1972). The structure and function of chromatin, Adv. Hum. Genet., 3, 237-431.

1043. Conner B. J., Reyes A. A., Morin C., Itakura K., Tepliz R. L., Wallace R. B. (1983). Detection of sickle ps-globin allele by hybridization with synthetic oligonucleotides, Proc. Natl. Acad. Sci. USA, 80, 278.

1044. Cori G. T., Cori C. F. (1952). Glucose-6-phos-phatase of the liver in glycogen storage disease, J. Biol. Chem., 199, 661.

1045. Costa Т., Scriver C. R., Childs B. (1985). The effect of Mendelian disease on human health: a measurement, Am. J. Med. Genet., 21, 231-242.

1046. Cotte J., Kissin C., Mathieu M., Poncet J., Monnet P., Salle В., German D. (1968). Observations on a case of partial deficiency of erythrocyte ATPase, Rev, Fr. Etudes Clin. Biol., 13, 284.

1047. Courtney M., Jaliat S., Tessier L.-H. Benavente A., Crystal R.G., bzcocq J.-P. (1985). Synthesis in E. coli of α₁-antitrypsin variants of therapeutic potential for emphysema and thrombosis, Nature, 313, 149-151.

1048. Cox R. P., Krauss M. R., Balis M. E., Dancis J. (1970). Evidence for transfer of enzyme product as the basis of metabolic cooperation between tissue culture fibroblasts of Lesch-Nychan disease and normal cells, Proc. Natl. Acad. Sci. USA, 67, 1573-1579.

1049. Dacie J. V., Mollison P. L., Richardson N., Selwyn J. G., Shapiro L. (1953). Atypical congenital haemolytic anemia, Q. J. Med., 22, 79.

1050. Dayer P., Balant L., Fabre J. (1984). The genetic control of drug oxidation in the liver, Internat. J. Chin. Pharmacol., 3, 421-425.

1051. Dayer P., Balant L., Kupfer A., Courvoisier F., Fabre J. (1983). Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenergic blocking agents, Eur. J. Clin. Pharmacol, 24, 787-799.

1052. Dean M. F., Muir H., Benson P. F., Button L. R., Boylston A., Mowbray J. (1976). Enzyme replacement therapy by fibroblast transplantation in a case of Hunter syndrome, Nature, 261, 323-326.

1053. De Bruyn C. H. M. M. (1976). Hypoxanthine-Guanine phosphoribosyl transferase deficiency, Hum. Genet, 31, 127-150.

1054. Diesseroth A., Nienhuis A., lawrence J., Giles R., Turner P., Ruddle F. H. (1978). Chromosomal localization on human P globin gene on human chromosome 11 in somatic cell hybrids, Proc. Natl. Acad. Sci. USA, 75, 1457-1460.

1055. Diesseroth A., Nienhuis A., Turner P., Velez R., Anderson W.F., Ruddle F., Lawrence J., Creagan R., Kucherlapati R. (1977). Localization of the human α-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay, Cell, 12, 205-218.

1056. Desnick R. J. (1979). Prospects for enzyme therapy in the lysosomal storage diseases of Ashkenazi Jews, pp. 253-270. In: Goodman R. M., Motulsky A. G. (eds.), Genetic diseases among Ashkenazi Jews, Raven Press, New York.

1057. Desnick R. J. (ed.) (1980). Enzyme therapy in genetic diseases, A Liss, New York.

1058. Desnick R. J., Grabowski G. A. (1981). Advances in the treatment of inherited metabolic diseases, Adv. Hum. Genet, 11, 281-369.

1059. Dicke W. K., Weijers H. A., van de Kamer J. H. (1953). Coeliac disease: the presence in wheat of a factor having a deleterious effect in cases of coeliac disease, Acta Paediatr., 42, 34-42.

1060. Diebold K., Hafner H., Vogel F., Schalt E. (1968). Die myoklonischen Varianten der familiaren amaurotischen Idiotie, Hum. Genet, 5, 119-164.

1061. Dittes H., Krone W., Bross K., Schmid M., Vogel W. (1975). Biochemical and cytogenetic studies on the nucleolus organizing regions (NOR) of man. II. A family with the 15-21 translocation, Hum. Genet, 26, 47-59.

1062. Drayer D. E., Reidenberg M.M. (1977). Clinical consequences of polimorphic acetylation of basic drugs, Clin. Pharmacol. Ther., 22, 251-258.

1063. Dugaiczyk A., Woo S. L. C., Iai E. C., Mace M. L. jr., McReynolds L., O'Malley B. W. (1978). The natural ovalbumin gene contains seven intervening sequences, Nature, 274, 328-333.

1064. Edwards Y. H., Hopkinson D. A., Harris H. (1971). Inherited variants of human nucleoside phosphorylase, Ann. Hum. Genet., 34, 395-408.

1065. Eichelbaum M., Bertilsson L., Sawe J., Zekorn C. (1982). Polymorphic oxidation of spatreine and debrisoquine: related pharmacogenetic entities, Clin. Pharmacol. Therap., 31, 184-186.

1066. Elston R. C., Graham J. В., Miller C.H., Reisner H. M., Войта В.М. (1976). Probabilistic classification of hemopholia A carriers by discriminant analysis, Thromb. Res., 8, 683-695.

1067. Emery A. E. H. (1980). Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis, Br. Med. Bull., 36, 117-122.

1068. Emery A. E. H., Anand R., Danford N.. Duncan W., Pawn L. (1978). Arylhydrocarbon-hydroxylase inducibility in patients with cancer, Lancet, I, 470-472.

1068a. Engel W. (1982). Geschlechtsdifferehzierung und ihre Storungen, Verh. Dtsch. Gesi Path, 66, 329-343.

1069. Epstein C. J. (1977). Inferring from modes of inheritance to the mechanisms of genetic disease. In: Rowland L. P. (ed.), Pathogenesis of human muscular dystrophies, Excerpta Medica, Amsterdam, pp. 9-22.

1070. Epstein C. J. (1985). Mouse monosomies and trisomies as axperimental systems for studying mammalian aneuploidy, TIG, 1, 129-134.

1071. Evans D. A. P. (1986). Pharmacogenetics. In: King R. A., Rotter J. I., Motulsky A. G. (eds.), The Genetic Basis of Common Disease, McGrawHill, New York (in press).

1072. Evans D. A. P., Harmer D., Downham D. Y., Whibley E. J., Idle J. R., Ritchie J., Smith R. L. (1983). The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distribution, J. Med. Genet, 20, 321-329.

1073. Evans D. A. P., Manley K., McKusick V. A. (1960). Genetic control of isoniazid metabolism in man, Br. Med. J., II, 485.

1074. Evans H. J. (1977). Facts and fancies relating to chromosome structure in man, Adv. Hum. Genet, 8, 347-438.

1075. Filip D. J., Eckstein J. D., Veltkamp J. J. (1976). Hereditary antithrombin III deficiency and thromboembolic disease, Am. J. Hematol., 2, 343-349.

1076. Fisch R. O., Simes L. K., Torres F., Anderson J. A. (1965). Studies on families of phenylketonurics, Am. J. Dis. Child., 109, 427-431.

1077. Flatz G. (1971). Population study of erythrocyte glutathione reductase activity. II. Hematological data of subjects with low enzyme activity and stimulation characteristics in their families, Hum. Genet., 11, 278-285.

1078. Flatz. G. (1971). Population study of erythrocyte glutathione reductase activity. I. Stimulation of the enzyme by flavin adenine dinucleotide and by riboflavin substitution, Hum. Genet., 11, 269-277.

1079. Flatz G., Xirotiris N. (1976). Glucose-6-phosp-hat-Dehydrogenase. In: Becker P. E. (ed.), Humangenetik, ein kurzes Handbuch, Vol. 1/3, Thieme, Stuttgart, pp. 495-535.

1080. Foiling A. (1934). Uber Ausscheidung von Phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitat, Hoppe Seylers Z. Physiol. Chem., 227, 169.

1081. Forbes G. B. (1953). Glycogen storage disease, J. Pediatr., 42, 645.

1082. Forget B. G. (1978). Molecular lesions in thalassemia, Trends in Biochemical Science, Vol. 3, 86-90.

1083. Forget B. G., Wilson J. Т., Wilson L. В., Cavallesco C., Reddy V. В., de Riel J. K., Biro A. P., Ghosh P. K., Weissman S.M. (1979). Globin mRNA structure: general features and sequence homology. In: Stamatoyannopoulos G, Nienhuis A. (eds.), Cellular and molecular regulation of hemoglobin switching, Grune and Stratton, New York, pp. 569-593.

1084. Franceschetti A., Klein D. (1954). Le depistage des heterozygotes. in: Gedda L. (ed.), Genetica medica, Orrizonte Midico, Rome.

1085. Eraser F. C., Walker B. E., Trasler D. G. (1957). Experimental production of congenital cleft palate: Genetic and environmental factors, Pediatrics [Suppl], 19, 782.

1086. Fratantoni J. С., Hall C. W., Neufeld E. F. (1968). Hunter and Hurler syndromes. Mutual correction of the defect in cultured fibroblasts, Science, 162, 570-572.

1087. Fredrickson D. S., Goldstein J. L., Brown M. S. (1978). The familial hyperlipoproteinemias. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), The metabolic basis of inherited disease, 4th ed., pp. 604-655, MaGraw-Hill, New York.

1088. Frezal J., Munnich A., Mitchell G. (1983). One gene, several messages. From multifunctional proteins to endogenous opiates, Hum. Genet., 56, 311-314.

1089. Friedman M. J. (1978). Erythrocytic mechanism of sickle cell resistance to malaria, Proc. Natl. Acad. Sci. USA, 75, 1994-1997.

1090. Friedmann Т., Seegmiller J. E., Subak-Sharpe J. H. (1968). Metabolic cooperation between genetically marked human fibroblasts in tissue culture, Nature, 220, 272-274.

1091. Garrod A. E. (1963). Inborn errors of metabolism, London 1923, reprinted by Oxford Univ. Press

1092. Geha R. S., Rosen R. S., Merler E. (1973). Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin: the cellular defect in X-linked agammaglobulinemia, J. Clin. Invest., 52, 1726-1734.

1093. Gelinas R., Endlich В., Pfeiffer C., Yagi M., Stamatoyannopoulos G. (1985). G to A substitution in the distal CCAAT box of the A y-globin gene in Greek hereditary persistence of fetal hemoglobin, Nature, 313, 323-325.

1094. Geisler M., Kleinebrecht J., Degenhardt K.-H. (1972). Histologische Analysen an triploiden Spontanaborten, Hum. Genet., 16, 283-294.

1095. Helb A. F., Klein E., Lieberman J. (1977). Pulmonary function in nonsmoking subjects with alpha 1 - antitrypsine deficiency (MZ phenotype), Am. J. Med., 62, 93.

1096. George D. L., Francke U. (1976). Gene dosage effect: regional mapping of human nucleoside phosphorylase on chromosome 14, Science, 194, 851-852.

1097. Gerhard D. S., Kidd K. K., Kidd J. R., Egeland J. A. (1984). Identification of a recent recombination event within the human β-globin gene cluster, Proc. Natl. Acad. Sci. USA, 81, 7875-7879.

1098. Giblett E. R., Anderson J. E., Cohen F., Foliarа В., Neuwissen H. J. (1972). Adenosine deaminase deficiency in two patients with severely impaired cellular immunity, Lancet, II, 1067-1069.

1099. Gibson Q. H. (1948). The reduction of methae-moglobin in red blood cells and studies on the cause of idiopathic methaemoglobulinaemia Biochem J., 42, 13-23.

1100. Gibson Q. H, Harrison D. C. (1947). Familial idiopathic methaemoglobinemia, Lancet, II, 941-943.

1101. Gilbert W. (1978). Why genes in pieces? nature, 271, 501.

1102. Glenner G. G., Ignaczak T. F., Page D. L. (1978). The inherited systemic amyloidoses and localized amyloid deposits. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds), The metabolic basis of inherited disease, 4th ed., McGraw-Hill, New York, pp. 1308-1339. (Summary 5th ed., pp. 1468-1469).

1103. Goedde H. W., Agarwal D. P. (1978). Pseudocholinesterase variation, International Titisee Conference, Titisee, 13-15, October 1977, Hum Genet. [Suppl. 1], 45-56.

1104. Goedde H. S., Altland K. (1971). Suxamethonium sensitivity, Ann. NY Acad. Sci., 179, 670-695.

1105. Goedde H. W., Altland K., Scholler K. L. (1967). Therapie der durch genetisch bedingte Pseudocholinesterase-Varianten verursachten verlangerten Apnoe nach Succinylcholin, Med. Klin., 62, 1631-1635.

1106. Coldschmidt R. B. (1935). Gen und Ausseneigenschaft (Untersuchungen an Drosophila) I. und II. Mitt. Z. Vererbungslehre, 10, 74-98.

1107. Goldstein J. L., Brown M. S. (1977). The lowdensity lipoprotein pathway and its relation to atherosclerosis, Ann. Rev. Biochem., 46, 897-930.

1108. Goldstein J. L., Brown M. S., Stone N. J. (1977). Genetics of the LDL receptor: evidence that the mutations affecting binding and internalization are alleliC., Cell, 12, 629-641.

1109. Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. (1973). Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, J. Clin. Invest., 54, 1544-1568.

1110. Gorrod J. W., Jenner P., Keysell G. R., Mikhael B. R. (1974). Oxidations metabolism of nicotine by cigarette smokers with cancer of the urinary bladder, J. Natl. Cancer Inst., 52, 1421-1424.

1111. Craham J. B. (1979). Genotype assignment (carrier detection) in the haemophilias. Clin. Haematol., 8, 115-145.

1111 A. Graham J. В., Barrow E. S., Reisner H. M., Edgell C. J. S. (1983). The genetics of blood coagulation, Adv. Hum. Genet., 13, 1-81.

1112. Gralnick H. R., Finlayson J. S. (1972). Congenital dysfibrinogenemias, Ann. Intern. Med., 77, 471-473.

1113. Grant D. M., Tang B. K., Kalow W. (1982). Polymorphic N-acetylation of a caffeine metabolite in man, Clin. Pharmacol. Therap., 33, 355-359.

1114. Griffin J. E., Wilson J. D. (1980). The syndrome of androgen resistance, N. Engl. J. Med., 302, 198-209.

1115. Gropp A., Kolbus U., Giers D. (1975). Systematic approach to the study of trisomy in the mouse. П. Cytogenet. Cell Genet., 14, 42-62.

1116. Guthrie R., Susi A. (1963). A simple phenylalanine method for detecting phenylketonuria in large populations of newborns, Pediatrics, 32, 338 XUl. Haldane J. B. S. (1954). The Biochemistry of Genetics, London.

1118. Hanel H. K., Cohn J., Harvald B. (1971). Adenosinetriphosphate deficiency in a family with nonspherocytic anaemia, Hum. Hered., 21, 313-319.

1119. Harper P. S. (1986). Carrier detection in Duchenne muscular dystrophy: a critical assessment, ProG. Med. Genet. N. S.

1120. Harvald В., Hanel H. K., Squires R., Trap-Jensen J. (1964). Adenosine - triphosphatase deficiency in patients with nonspherocytic hemolytic anemia, lancet, II, 18.

1121. Herrick J. B. (1910). Peculiar elongated and sickleshaped red blood corpuscles in a case of severe anemia, Arch. Intern. Med., 6, 517.

1122.Higgs D. R., Hill A. V. S., Micholls R., Goodbourn S. E. Y., Ayyub H., Teal H., Clegg J. В., Weatherall D. J. (1985). Molecular rearrangements of the human α-gene cluster, Ann. NY Acad. Sci., 445, 45-56.

1123. Hilschmann N., Kratzin H., Altevogt P., Ruban E., Kortt A., Staroscik C., Scholz R., Palm W, Barnikol H.-U., Barnikol-Watanabe S., Bertram J., Horn J., Engelhard M., Schneider M., Dreher W. (1976). Evolutionary origin of antibody specificity. In: Goodman M., Tashian R. E. (eds.), Molecular anthropology, Plenum Press, New York, London, pp. 369-386.

1124. Hilschmann N., Watanabe S., Barnikol H. U., Laure C. J., Bertram J., Horn J., Engelhard M., Schneider M., Dreker L. (1975). Die Rolle der Evolution im Immunsystem, Nova Acta Leopoldina, 42, 189-222.

1125. Hirsch W., Мех A., Vogel F. (1967). Metabolic traits in mentally retarded children as compared with normal populations: Phenylalanine and tyrosine in serum and urine, J. Ment. Defic. Res., 11, 212-227.

1126. Hirschhorn R., Beratis N., Rosen F. S., Parkman R., Stern R., Polmar S. (1975). Adenosine deaminase deficiency in a child diagnosed prenatally, Lancet, I, 73-75.

1127. Hirschhorn R., Martiniuk F., Rosen F. S. (1979). Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency, Clin. Immunol. Immunopathol, 14, 107-120.

1128. Hirschhorn R., Weissmann G. (1976). Genetic disorders of Lysosomes, ProG. Med. Genet. [New Series], 1, 49-101.

1129. Hoof F. van, Hers H. G. (1964). Ultrastructure of hepatic cells in Hurler's disease (gargoylism), Cr Acad. Sci. [D] (Paris), 259, 1281.

1130. Horlein H., Weber G. (1948). Uber chronische familiare Methamoglobinamie und eine neue Modification des Methamoglobins, Dtsch. Med. Wochenschr., 72, 476.

1131. Howell R. R. (1972). Genetic disease: The present status of treatment, Hosp. Pract, 7, 75-84.

1132. Howell R. R., Stevenson R.E. (1971). The offspring of phenylketonuric women, Soc. Biol., 18, 519-529.

1133. Howell D. R., Williams J. С (1983). The glycogen stoarage diseases. In Stanbury et al. (eds.), The metabolis basis of inherited disease, 5th ed., McGraw-Hill, New York etc., pp. 141-166.

1134. Hsia D. Y.-Y. (1957). The laboratory detection of heterozygotes, Am. J. Hum. Genet., 9, 97-116.

1135. Huehns E. R., Dance N., Beaven G. H., Hecht F., Motulsky A. G. (1964). Human embryonic hemoglobins, Cold Spring Harbor Symp. Quant. Biol., 29, 327-331.

1136. Huisman Т. Н. J., Wilson J. В., Gravely M., Hubbard M. (1974). Hemoglobin Grady: The first example of a variant with elongated chains due to an insertion of residues. Proc. Natl. Acad. Sci. USA, 71, 3270-3273.

1137. Huisman T. J. H., Wrightstone R.N., Wilson J. В., Schroeder W. A., Kendall A. G. (1972). Hemoglobin Kenya, the product of fusion of у and P polypeptide chains, Arch. Biochem. Biophys., 153, 850-853.

1138. Ingram V. M. (1956). A specific difference between the globins of normal human and sickle cell anaemia haemoglobin, Nature, 178, 792.

1139. Ingram V. M. (1957). Gene mutations in human haemoglobin: The chemical difference between normal and sickle cell hemoglobin, Nature, 180, 325-328.

1140. Jacob F. (1978). Mouse teratocarcinoma and mouse embryo, The Leuwenhoek lecture 1977, Proc. R. SoC., Lond. [Biol.], 201, 249-270.

1141. Jacob F., Monod J. (1961). On the regulation of gene activity, Cold Spring Harbor Symp. Quant. Biol., 26, 193-209.

1142. Jawll J. H., Cooper R. A. (1978). Hereditary Spherocytosis. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), The metabolic basis of inherited disease, 4th ed., McGraw-Hill, New York, pp. 1396-1409.

1143. Jeffreys A. J. (1979). DNA sequence variants in Cry-, Ay-, 5- and P-globin genes of man, Cell, 18, 1.

1144. Jervis G. A. (1953). Phenylpyruvic oligophrenia: Deficiency of phenylalanine oxidizing system, Proc. Soc. Exp. Biol. Med., 82, 514-515.

1145. Jones M. E. (1980). Pyrinidine hucleotide biosynthesis in animals: Genes, enzymes, and regulation of UMP biosynthesis, Ann. Rev. Biochem., 49, 253-279.

1146. Kahn A. (1978). G6PD variants, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genet. [Suppl. 1], 37-44.

1147. Kahn A., Etiemble J., Meienhofer M. C., Boivin P. (1975). Erythrocyte phosphodructokinase deficiency associated with an unstable variant of muscle phosphofructokinase, Clin. Chim. Acta, 61, 415.

1148. Kahn A., Kaplan J.-C., Dreyfus J.-C. (1979). Advances in hereditary red cell enzyme anomalies, Hum. Genet., 50, 1-27.

1149. Kahn A., Marie J., Galand C., Boivin P. (1975). Molecular mechanism of erythrocyte pyruvate kinase deficiency, Hum. Genet., 29, 271-280.

1150. Kalckar H. M. (1957). Biochemical mutations in man and microorganism, Science, 125, 105-108.

1151. Kalow W. (1982). The metabolism of xenobiotics in different populations, Can. J. Physiol. Pharmacol, 60, 1-12.

1152. Kalow W., Star on N. (1957). On distribution and inheritance of human serum cholinesterase, as indicated by dibucaine numbers, Can. J. Biochem., 35, 1305.

1153. Kalter H., Warkany J. (1983). Congenital malformations. Etiologic factors and their role in prevention, N. Engl. J. Med., 308, 424-431.

1154. Kalter H., Warkany J. (1983). Congenital malformations. N. Engl. J. Med. 308, 491-497.

1155. Kamuzora H., Lehmann H. (1975). Human embryonic haemoglobin including a comparison by homology of the human e and a chains, Nature, 256, 511-513.

1156а. Kan. Y. W. (1985). Molecular pathology of a-thalassemia, Ann. NY Acad. Sci., 445, 28-35

1156b. Kan. Y. W., Chang J. C., Poon R. (1979). Nucleotide sequences of the untranslated 5' and 3' regions of human a- p- and y-globin mRNAs. In: Stamatoyannopoulos G., Nienhuis A. (eds.), Cellular and molecular regulation of hemoglobin switchinG. Grune and Stratton, New York, pp. 595-606.

1157. Kan Y. W., Dozy A. M. (1978). Polymorphism of DNA sequence adjacent to the human P globin structural gene, Its relation to the sickle mutation, Proc. Natl. Acad. Sci. USA, 75, 5631-5635.

1158. Kan Y. W., Dozy A.M., Trecartin R., Todd D. (1977). Identification of a nondeletion defect in a-thalassemia, N. Engl. J. Med., 297, 1081-1084.

1158a. Kappas A., Sassa S., Anderson K. E. (1983). The porphyrias. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S., Goldstein J. L., Brown M. S. (eds.), The metabolic Basis of inherited Disease, 5th ed., McGraw-Hill, New York.

1159. Kazazian H. H., Cho S., Phillips J. A. Ill (1977). The tational basis of the thalassemia syndromes, ProG. Med. Genet., 2, 165-204.

1160. Kellermann G., Iuyten-Kellerman M., Shaw C. R. (1973). Gentic variation of aryl hydrocarbon hydroxylase in human lymphocytes, Am. J. Hum. Genet, 25, 327-331.

1161. Kellermann G., Shaw C. R., Iuyten-Kellerman M. (1973). Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma, N. Engl. J. Med., 289, 934.

1162. Kelley W. T. V., Greene M. L., Rosenbloom F. M., Henderson J. F., Seegmiller J. E. (1969). Hudro-xanthine-guanine phosphoribosyl transferase in gout, Ann. Intern. Med., 70, 155-206.

1163. Kelly W. N., Wyngaarden J. B. (1970). Studies on the purine phosphoribosyltransferase enzymes in fibroblasts from patients with the Lesch-Nyhan syndrome, Clin. Res., 18, 394.

1164. Kelly W. J., Wyngaarden J.B. (1983). Clinical syndromes associated with HPRT deficiency. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D.S., Goldstein J.L., Brown M. S. (eds.), The metabolic basis of inherited disease, 5th ed., McGraw-Hill, New York, pp. 1115-1143.

1165. Kendrew J. C., Dicker son R. E., Strandberg B. E., Hart R. G., Davies D. R., Phillips D. С, Shore V.C. (1960). Structure of myoglobina threedimensional Fourier synthesis at 2 A. Resolution, Nature, 185,422-427.

1166. Kirkman H. N. (1972). Enzyme defect, Pro G. Med. Genet., 8, 125-168.

1167. Kirkman H. N., Hendrickson E. M. (1963). Sex-linked electrophoretic difference in glucose-6-phosphate dehydrogenase, Am. J. Hum. Genet, 15, 240.

1167a. Knowlton R. G. et al. (1985). A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7, Nature, 318, 380-382.

1168. Knudson A. G., DiFerrante A. Curts F. J. (1971). The effect of Leucocyte transfusion in a child with MPS type I, Proc. Natl. Acad. Sci. USA, 68, 1738-1741.

1169. Knussmann R. (1973). Unterschiede zwischen Mutter-Kind- und Vater-Kind-Korrelationen im Hautleistensystem des Menschen, Hum. Genet, 19, 145-154.

1170. Koch E., Bohn H., Koch F. (1964). Mucoviscidosis, Schattauer, Stuttgart.

1171. Korenberg J., Therman E., Denniston C. (1978). Hot spots and functional organization of human chromosomes, Hum. Genet., 43, 13-22.

1172. Kornberg R. D. (1977). Structure of chromatin, Ann. Rev. Biochem., 46, 931-945.

1173. Krangel M. S., Orr H. T., Strominger J. L. (1980). Structure, function and biosynthesis of the major human histocompatibility antigens (HLA-A and HLA-B), Scand. J. Immunol., 11, 561-571.

1174. Kresse H., Cantz M., von Figura K., Glossl J., Paschke E. (1981). The mucopolysaccharidoses: Biochemistry and clinical symptoms, Klin. Wschr., 59, 867-876.

1175. Kresse A., Neufeld E. F. (1972). The Sanfilippo A corrective factor. Purification and mode of action, J. Biol. Chem., 247, 2164,

1176. Krone W., Wolf U. (1978). Chromosome and protein variation. In: Brock D. S. H., Mayo O. (eds.), The Biochemical Genetics of Man, 2nd ed., Academic Press, New York, London.

1177. Krooth R. S., Weinberg A. N. (1961). Studies of patients with galactosemia, J. Exp. Med., 133, 1155-1171.

1178. Kuhn A. (1961). Grundriss der Vererbungslehre, Quelle and Meyer, HeidelberG.

1179. Kukharenko V.I., Kuliev A.M., Grinberg K.N., Terskikh V. V. (1974). Cell cicles in human diploid and aneuploid strains, Hum. Genet., 24, 285-296.

1180. Kulazenko V. P. (1974). Morphogenetic disturbances in a spontaneous abortus with trisomy, 13 Hum. Genet., 25, 53-59.

1181. Kuliev A. M., Kukharenko V. I., Grinberg K. N., Vasileysky S. S., Terskikh V. V., Stephanova L. G. (1973). Morphological, autoradiographiC., immunochemical and cytochemical investigation of a cell strain with trisomy 7 from a spontaneous abortion. Hum. Genet., 17, 285-296.

1182. Kuliev A. M., Kukharenko V. I., Grinberg K. N., Terskikh V. V., Tamarkina A. D., Begomazov E. A., Vasileysky S. S. (1974). Investigation of a cell strain with trisomy 14 from a spontaneously aborted human fetus, Hum. Genet, 21, 1-12.

1183. Kuliev A. M., Kukharenko V. I., Grinberg K. N., Mikhailov А. Т., Tamarkina A. D. (1975). Human triploid cell strain. Phenotype on cellular level, Hum. Genet., 30, 127-134.

1184. Kupfer A., Preisig R. (1984). Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man, Eur J. Clin. Pharmacol, 26, 753-759.

1185. Kurnit D. M. (1979). Down syndrome: gene dosage at the transcriptional level in skin fibroblasts, Proc. Natl. Acad. Sci. USA, 76, 2372-2375.

1186. lambert В., Hansson K., Bui Т. Н., Funes-Carvicto F., Lindsten J., Holmberg M., Strausmanis R. (1976). DNA repair and frequency of X-ray and u.v.-light induced chromosome. Aberrations in leukocytes from patients with Down's syndrome, Ann. Hum. Genet., 39, 293-302.

1187. Landauer W. (1957). Phenocopies and genotype with special reference to sporadically occurring developmental variants, Am. Naturalist, 91, 79-90.

1188. Lang A., lorkin P. A. (1976). Genetics of human haemoglibins, Br. Med. Bull, 32, 239-245.

1189. Lawn R. M., Efstratiadis A., O'Connell C., Maniatis T. (1980). The nycleotide sequence of the human betaglobin gene, Cell, 21, 647-651.

1190. Layzer R. B., Rowland L. P., Bank W. J. (1969). Physical and kinetic properties of human phosphofructokinase from skeletal muscle and erythrocytes, J. Biol. Chem., 244, 3823.

1191. Layzer R. B., Rowland L. P., Ramey H.M. (1967). Muscle phosphofructokinase deficiency, Arch. Neurol., 17, 512.

1191a. Leder P. (1978). Discontinuous genes, N. Engl. J. Med., 298, 1079-1081.

1192. Leder P. (1982). The genetics of antibody diversity, Sci. Am., 246, 102-115.

1193. Leder P., Tilghman S., Tiemeier D., Kunkel D., Seidman J. G. (1979). The organisation of mouse P-globin genes. In: Stamatoyannopoulos G., Nienhuis A. (ed.), Cellular and molecular regulation of hemoglobin switching, Grune and Stratton, New York, pp. 493-500.

1194. Lehmann H., Kynoch P. A. M. (1976). Human haemoglobin variants and their characteristics, North-Holland. Amsterdam.

1195. Lehmann H., Ryan E. (1956). The familial incidence of low pseudocholinesterase level, Lancet, II, 124.

1196. Lemke R. R., Levy H. L. (1980). Maternal phenylketonuria and hyperphenylalaninemia: An international survey of the outcome of untreated and treated pregnancies, New England J. Med., 303, 1202.

1197. Leroy J. G. (1983). The oligosaccharidoses (formerly mucolipidoses). In: Emery A. E. H., Rimoin D. L., (eds.), Principles and Practice of Medical Genetics, Vol. 2, Churchill Livingstone, Edinburgh etc., pp. 1348-1365.

1198. Lesch M., Nyhan W. L. (1964). A femilial disorder of uric acid metabolism and central nervous system function, Am. J. Med., 36, 561.

1199. Levin S., Moses S. W., Chayoth R., Jagoda N.. Steinitz K., Levinson G. (1967). Glycogen storage disease in Israel, Isr. J. Med. Sci., 3, 397-410.

1200. Uebhaber S. A., Goossens M. J., Kan Y. W. (1980). Cloning and complete sequence of human 5'-alpha-globin gene, Proc. Natl. Acad. Sci. USA, 77, 7054-7058.

1201. Liebhaber S. A., Rappaport E. F., Cash E. F., Ballas S. K., Schwartz E., Surrey S. (1984). Hb I mutation encoded at both globin loci on the same chromosome: Concerted evolution in the human genome, Science, 226, 1449-1451.

1202. Lison M., Blondheim S. H., Melmed R. N. (1980). A polyporphism of the ability to smell urinary metabolites of asparagus, Br. Med. J., 281, 1676-1678.

1203. Lohr G. W. (1969). Genetische Enzymdefekte der Hexokinase und der Transport-Adenosin-Triphosphat-Phosphohydrolase der Erythrozyten, Folia Haematol., 91, 28.

1204. Lunde P. K. M., Frislid K., Hansteen V (1911). Disease and acetylation polymorphism Clin. Pharmacokin., 2, 182-197.

1205. Lyon W. F., Hawkes S. G. (1970). An X-linked gene for testicular feminization of the mouse, Nature, 227, 1217-1219.

1206. Mabuchi H., Haba T., Veda K., Ueda R., Tatami R., Ito S., Kametani T., Koizumi J., Miyamoto S., Ohta M., Takeda R., Takegoshi T., Takeshita H. (1977). Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku district of Japan, Atherosclerosis, 28, 417-423.

1207. Magnuson Т., Epstein C. J. (1981). Genetic control of very early mammalian development, Biol. Rev, 56, 369-408.

1208. Mars R. de (1964). Some studies of enzymes in cultivated human cells. In: Metabolic control mechanisms in animal cells, Natl. Cancer Inst. Monogr., 13, 181-193.

1209. Martin G. R., Epstein С. J., Travis В., Tucker G., Yatziv S., Martin D. W., ir., Clift S., Cohen S. (1978). X-chromosome inactivation during differentiation of female teratocarcinoma stem cells in vitro, Nature, 217, 329-333.

1210. Martinez J., Holburn R. R., Shapiro S., Ersley A. J. (1974). Fibrinogen Philadelphia: a hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism, J. Clin. Invest, 53, 600.

1211. May A., Huehns E. R. (1976). The mechanism and prevention of sickling, Br. Med. Bull., 32, 223-233.

1212. McDevitt H., Bodmer W. (1974). HLA immuneresponse genes and disease, Lancet, I, 1269-1274.

1213. McLaren A., Simpson E., Tomonari K., Chandler P., Hogg H. (1984). Male sexual differentiation in mice lacking H-Y antigen, Nature, 312, 552-555.

1214. McKee P. A. (1983). Hemostatis and disorders of blood coagulation. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S., Goldstein J. L., Brown M. S. (eds.), The metabolic basis of inherited disease, 5th ed., McGraw-Hill Book Co., New York etc. pp. 1531-1560.

1215. McPherson E., Taylor С. A., Jr. (1982). The genetics of malignant hyperthermia: evidence for heterogeneity, Am. J. Med. Genet., 11, 273-285.

1216. Mears J. G., Ramirez F., Leibowitz D., Nakamura F., Bloom F., Konotey - Ahulu F., Bank A. (1978). Changes in restricted human cellular DNA fragments containing globin gene sequences in thalassemias and related disorders, Proc. Natl. Acad. Sci. USA, 75, 1222-1226.

1217. Meyer R. A., Schmid R., (1978). The porphyrias. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), The metabolic basis of inherited disease, 4th ed., McGraw - Hill, New York, pp. 1166-1220. 1218. Miller M., Opheim K.E., Raisys V.A., Motulsky A. G. (1984). Theophylline metabolism: variation and genetics, Clin. Pharmacol. Therap., 35, 170-182.

I 1219. Minder E. I., Meier P. J., Muller H. K., Minder C., Meyer U.A. (1984). Bufuralol metabolism in human liver: a sensitive probe for the debrisoquinetype polymorphism of drug oxidation, Eur. J. Clin. Invest., 14, 184-189.

1220. Morris J. M. (1953). The syndrome о testicular feminization in male pseudohermaphrodites, Am. J. Obstet. Gynecol., 65, 1192.

1221. Moser H. (1984). Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention, Hum. Genet., 66, 17-40.

1222. Motulsky A. G. (1957). Drug reactions, enzymes and biochemical genetics, J. Am. Med., AssoC., 165, 835-837.

1223. Motulsky A. G. (1964). Current concepts of the genetics of the thalassemias, Cold Spring Harbor Symp. Quant. Biol., 29, 399^13.

1224. Motulsky A. G. (1965). Theoretical and clinical problems of glucose-6-phsphate dehydrogenase deficiency. In:. Jonxis J. P. H. (ed.), Abnormal haemoglobins in Africa, Blackwell, Oxford, pp. 143-196a.

1225. Motulsky A. G. (1972). Hemolysis in glucoses-phosphate dehydrogenase deficiency, Fed. ProC., 31, 1286-1292.

1226. Motulsky A. G. (1973). Frequency of sickling disorders in US blacks, N. Engl. J. Med, 288, 31-33.

1227. Motulsky A. G. (1975). Glucose-6-phosphate dehydrogenase and abnormal hemoglobin polymorphism-evidence regarding malarial selection. In: Salzano F. M. (ed.), The role of natural selection in human evolution, North-Holland, Amsterdam, pp. 271-291.

1228. Motulsky A. G. (1977). Ecogenetics: genetic variation in susceptibility to environmental agents, In: Human genetics, Proceedings of the 5th International Congress of Human Genetics, Mexico City, 10-15 October 1976, Excerpta Medica, Amsterdam, pp. 375-385.

1229. Motulsky A. G. (1978). Multifactorial inheritance and heritability in pharmacogenetics, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genet. [Suppl. 1], 7-12.

1230. Motulsky A. G. (1970). Biochemical genetics in hemoglobins and enzymes as a model for birth defect research. In: Frazer F. C., Mc-Kusick V. A. (eds.), Congenital malformations, Excerpta Medica, Amsterdam, p. 199.

1231. Mueller R. F., Hornung S., Furlong C. E., Anderson J., Giblett E. R., Motulsky A. G. (1983). Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies, Am. J. Hum. Genet, 35, 393-408.

1232. Nagel R. L., Fabry M. E., Pagnier J., Zouhoun I., Wajcman H., Baudin V., labie D. (1985). Hematological and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type, N. Engl. J. Med, 312, 880-884.

1233. Nage R. L., labie D. (1985). The consequences and inplications of the multicentric origin of the Hb S gene. In: Stamatoyannopoulos G, Nienhues A. (eds.), Experimental Approaches for the Study of Hemoglobin Switching, Alan R. Liss, New York, pp. 93-103.

1234. Nance W. E. (1975). Genetic studies of human serum and erythrocyte polymorphism, University of Wisconsin, Ph.D. Dissertation 1967, Quoted in: Harris H, The principles of human biochemical genetics, North-Holland, Amsterdam, pp. 163.

1235. Nebert D. W., Goujon F. M., Gielen J. E. (1972). Aryl hydrocarbon hydroxilase induction by polycyclic hydrocarbons: Simple autosomal dominant trait in the mouse, Nature, New Biol, 236, 107.

1235a. Neel J. V. (1949). The inheritance of sickle cell anemia, Science, 110, 64.

1236. Neel J. V. (1949-1950). The detection of the genetic carriers of hereditary disease, Am. J. Hum. Genet, 1/2, 19-36.

1237. Neel J. V. (1953). The detection of the genetic carriers of inherited disease. In: Sorsby A. (ed.), Clinical genetics, Mosby, St. Louis, p. 27.

1238. Nienhuis A. W., Аnаgnоu N. P., Ley T. J. (1984). Advances in thalassemia research, Blood, 63, 738-757.

1239. Nelson Т. Е., Flewellen E. H. (1983). The malignant hyperthermia syndrome, N. Engl. Med, 309, 416-418.

1240. Neufeld E. F. (1974). The biochemical basis for mucopolysaccharidoses and mucolipidoses, ProG. Med. Genet., 10, 81-101.

1241. Neufeld E. F., Barton R. W. (1972). Genetic disorders of mucopolysaccharide metabolism. In: Gaull G. E. (ed.), Biology of brain dysfunction, pp. 1-30, Plenum, New York.

1242. Neufeld E. F., McKusickV.A. (1983). Disorders of lysosomal enzyme synthesis and localization: I-cell disease and Pseudo-Hurler polydystrophy. In: Stanbury J. B. et al. (eds.), The metabolic basis of inherited disease, 5th ed., McGraw-Hill Book Co, New York, etc., pp. 778-787.

1243. New S. L., Levine L. S. (1973). Congenital adrenal hypoplasia, Adv. Hum. Genet., 4, 251-326.

1244. Ng W. G., Rae T. F., DonnellG. N. (1983). Disorders of carbohydrate metabolism. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and practice of medical genetics, Churchill Livingstone, Edinburgh etc., pp. 1267-1285.

1245. Niebuhr E. (1974). Triploidy in man, Hum. Genet, 21, 103-125.

1246. Nienhuis A. W (1978). Mapping the human genome, N. Engl. J. Med., 299, 195-196.

1247. Norum K. R. (1978). Genetic and nongenetic hyperlipidemia and Western diet, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genetic. [Supl. 1], 125-130.

1248. Ohno S. (1976). A hormonelike action of H-Y antigen and gonadal development of XY/XX mosaic males and hermaphrodites, Hum. Genet., 35, 21-25.

1249. Ohno S. (1976). Major regulatory genes for mammalian development, Cell, 7, 315-321.

1250. Omenn G. S., Motulsky A. G. (1978). "Ecogenetics": genetic variation in susceptibility to environmental agents. In: Cohen В. Н., Lilienfeld A. M., Huang P. C. (eds.), Genetic issues in public health and medicine, pp. 83-111, Thomas, Springfield.

1252. Orkin S. H., Alter B. P., Italy C., Mahoney M. J., Lasarus H., Hobbins J. C., Nathan D. G. (1978). Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion, N. Engl. J. Med., 299, 166-172.

1253. Orkin S. H., Kazazian H. H. Jr. (1984). The mutation and polymorphism of the human β-globin gene and its surrounding area, Ann. Rev. Genet, 18, 131-171.

1254. Orkin S. H., Markham A.F., Kazazian H.H. (1983). Direct detection of the common Mediterranean thalassemia gene with synthetic DNA probes. An alternative approach for prenatal diagnosis, J. Clin. Invest, 71, 775.

1255. Ortigoza-Ferado J., Richter R. J., Hornung S. K., Motulsky A. G., Furlong С. Е. (1984). Paraoxonase hydrolysis in human serum mediated by a genetically variable aryle-sterase and albumin, Am. J. Hum. Genet, 36, 295-305.

1256. Osborne W. R. A., Chen S. H, Giblett E. R., Biggar W. D., Ammann A. J., Scott C. R. (1977). Purine nucleoside phosphorylase deficiency: evidense for molecular heterogeneity in two families with enzyme deficient members, J. Clin. Invest, 60, 741-746.

1257. Ottolenghi S., Comi P., Giglioni В., Tolstoshev P., Lanyon W. G., Mitchell G. J., Williamson R., Russo G., Musumeci S., Schiliro G., Tsistrakis G. A., Car ache S., Wood W. G., Clegg J. В., Weather all D. J. (1976). 8f3 thalassemia is due to a gene deletion, Cell, 9, 71.

1258. Otton S. V., Inaba Т., Kalow W. (1983). Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs, Life Scienses, 32, 795-800.

1259. Paigen В., Gurtoo H. G., Minowada J. et al. (1977). Questionable relation of aryl hydrocarbon hydroxylase to lungcancer risk, N. Engl. J. Med, 297, 346-350.

1260. Pauling L., Itano HA., Singer S. J., Wells I. C. (1949). Sickle cell anemia: a molecular disease, Science 110 543.

1261. Pearl E. R., Vogler L. B., Okos A. J., Crist W. M., Lawton A.R. Ill, Cooper M.D. (1979). B-lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody deficiency states, J. Immunol, 120, 1169-1175.

1262. Penrose L. S. (1935). Inheritance of phenyl-pyruvic anemia (Phenylketonuria), Lancet, II, 192-194.

1263. Penrose L. S., Quastel J. H (1937). Metabolic studies in phenylketonuria, Biochem. J, 31, 266-271.

1264. Percy A. K. (1983). The gangliosidoses and related lipid storage diseases. In: Emery A. E. H, Rimoin D. L. (eds.), Principles and practice of medical genetics, Vol. 2, Churchill Livingstone, Edinburgh etC., pp. 1366-1388.

1265. Perutz M. F. (1976). Structure and mechanism of haemoglobin, Brit. Med. Bull, 32, 195-208.

1266. Polmar S. H., Stern R. C., Schwartz A. L, Wetzler E. M., Chase P. A., Hirschhorn R. (1976). Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency, N. Engl. J. Med, 295, 1337-1343.

1267. Polmar S. H., Wetzler E. M., Stern R. C., Martin D. W. Jr. (1978). Evidence for the role of ribonucleotide reductase inhibition in adenosine deaminase deficiency, Pediatr. Res.

1268. Price Evans D. A. (1984). Survey of the human acetylator polymorphism in spontaneous disorders, J. Med. Genet, 21, 243-253.

1269. PrinsH. K., OortM., Loos J. A. Zurcher C., Beckers T. (1966). Congenital nonspherocytic hemolytic anemia associated with glutathione deficiency of the erythrocytes, Blood, 27, 145.

1270. Propping P. (1978). Pharmacogenetics Rev. Physiol. Biochem. Pharmacol, 83, 124-173.

1271. Propping P. (1984). Genetic aspects of neurotoxicity. In: Blum K, Manzo L. (eds.), Neurotoxicology, Marcel Dekker Inc., New York, pp. 203-218.

1272. Proudfoot N. J., Brownlee G. G. (1976). Nucleotide sequences of globin messenger RNA, Br. Med. Bull, 32, 251-256.

1273. Proudfoot N. J., Gil A., Maniatis T. (1982). The structure of the human zeta globin gene and a closely linked nearly identical pseudo-gene, Cell, 31, 553.

1274. Руке К. W., Dosch H.-M., Ipp M. M., Gelfand E. W. (1975). Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease, N. Engl. J. Med., 295, 424-428.

1276. Raghuram T. C., Koshakji R. P., Wilkinson G. R., Wood A. J. J. (1984). Polymorphic ability to metabolize propanolol alters 4-hydroxy propanolol levels but not beta-blockade, Clin. Pharmacol. Therapy, 36, 51-56.

1277. Ratnoff O. D. (1978). Hereditary disorders of hemostasis. In: Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), The metabolic basis of inherited disease, 4th ed., McGraw-Hill, New York, pp. 1755-1791.

1278. Ratnoff O. D., Jones P. K. (1977). The laboratory diagnosis of the carrier state for classic hemophilia, Ann. Intern. Med., 86, 521.

1279. Reed Т., Young R. S. (1982). Maternal effects in dermatoglyphics: Similarities from twin studies among palmar, plantar and fingertip variables, Am. J. Hum. Genet., 34, 349-352.

1280. Reidenberg M. M., Drayer D. E. (1978). Aromatic amines and hydrazines, drug acetylation, and lupus erythematosus, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genet. [Suppl. 1], 57-64.

1281. Ricco G., Mazza U., Turi R. M., Pich P. G., Camaschella C., Saglio G., Benini L. F. (1976). Significance of a new type of human fetal hemoglobin carrying a replacement isoleu-cinethreonine at position 74 (E19) of the у chain, Hum. Genet., 32, 305-313.

1282. Romeo G. (1977). Analytical review, Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level, Hum. Genet., 39, 261-276.

1283. Rott H. D., Mulz D. (1983). Duchenne's muscular dystrophy: Carrier detection by muscle ultrasound, J. Genet. Hum., 31, 63-65.

1284. Ruddy S., Austen K. F. (1978). Inherited abnormalities of the complement system, In: The metabolic basis of inherited disease, 4th ed., Stanbury J. В., Wyngaarden J. В., Fredrickson D. S. (eds.), McGraw-Hill, New York, pp. 1737-1754.

1285. Sahi T. (1978). Intestinal lactase polymorphism and dairy foods, International Titisee Conference, Titisee, 13-15 October 1977, Hum. Genet. [Suppl. 1], 115-124.

1286. SandhoffK. Christomanou H. (1979). Biochemistry and genetics of gangliosidoses, Hum. Genet., 50, 107-143.

1287. Scott С. R. (1983). Disorders of amino acid metabolism. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and Practice of Medical Genetics, Churchill Livingstone, Edinburgh etc., pp. 1241-1266.

1288. Scott С. I. (1973). The genetics of short stature. ProG. Med. Genet., 8, 243-299.

1289. Scriver C. R. (1969). Treatment of inherited disease: Realized and potential, Med. Clin. North Am., 53, 941-963.

1290. Scriver C. R., Clow С. L. (1980). Phenylketonuria and other phenylalanine hydroxylase mutants in man, Ann. Rev. Genet., 14, 179-202.

1291. Scriver C. R., Mackenzie S., Clow C. L., Delvin E. (1972). Thiamineresponsive maple syrup urine disease, Lancet, 1, 310-312.

1292. Sears D. A. (1978). The morbidity of sickle cell trait. A review of the literature, Am. J. Med., 64, 1021-1036.

1293. Seegmiller J. E. (1980). Disease of purine and pyrimidine metabolism. In: Bondy P. K., Rosenberg L. E. (eds.), Metabolic control and disease, 8th ed., W. B. Saunders Cop., Philadelphia, pp. 777 937.

1294. Seegmiller J. E. (1983). Disorders of purine and pyrimidine metabolism. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and Practice of Medical Genetics, Churchill Livingstone, Edinburgh etc., pp. 1286-1305.

1295. Seegmiller J. E., Rosenbaum F. M., Kelly W. N. (1967). An enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis, Science, 155, 1682.

1296. Seidegaard J., Pero R. W. (1985). The hereditary transmission of high glutathione transferase activity towards transstilbene oxide in human mononuclear leukocytes, Hum. Genet., 69, 66-68.

1297. Semenza G. (1981). Intestinal oligo- and disac-charides. In: Randle P. J., Steiner D. F., Whelan W. J. (eds.), Carbohydrate metabolism and its disorders, Vol. 3, Academic Press, London, pp. 425-479.

1298. Serjeant G. R. (1974). The clinical features of sickle cell disease, Clinical Studies. IV. North Holland, Amsterdam.

1299. Sibert J. R., Harper P. S., Thompson R. J. et al. (1979). Carrier detection in Duchenne muscular distrophy. Evidence from a study of oligatory carrier and mothers of isolated cases, Arch. Dis. Child, 54, 534-537.

1300. Simpson J.L. (1983). Disorders of gonads and internal reproductive ducts. In: Emery A. E. H, Rimoin D. L. (eds.), Principles and practice of medical genetics, Churchill Livingstone, Edinburgh, pp. 1227-1240.

1301. Siniscalco M. (1979). Approaches to Human Linkage. Progress in Medical Genetics, NS Vol. 3, Saunders, Philadelphia, pp. 221-307.

1302. Singh R. P., Carr D. H. (1967). Anatomic findings in human abortions of known chromosomal constitution, Obstet. Gynecol., 29, 806.

1303. Sinnot E. W., Dunn L. C., Dobzhansky T (1958). Principles of genetics, 5th ed., McGraw-Hill, New York.

1304. Slighton J.L., Blechl A.E., Smithies O. (1980). Human fetal G-gamma- and A-gamma-globulin genes: complete nucleotide sequences suggest that DNA can be exchanged in these duplicated genes, Cell, 21, 627-638.

1305. Sloan T. P., Mahgoub A., Lancaster R, Idle J.R., Smith R. L. (1978). Polymorphism of carbon oxidation of drugs and clinical implications, Br. Med. J., 2, 655-657.

1306. Sly W. S., Achard D. Т., Kaplan A. (1977). Correction of enzyme deficient fibroblasts: Evidence for a new type of pinocytosis receptor which mediates uptake of lysosomal enzymes, (Abstract) Clin. Res., 25, 471 A.

1307. Smithies O. (1955). Grouped variations in the occurence of new protein components in normal human serum, Nature, 175, 307-308.

1308. Smithies O. (1955). Zone electrophoresis in starch gels: Group variations in the serum proteins of normal human adults, Biochem. J., 61, 629-641.

1309. Spencer N., Hopkinson D. A., Harris H. (1968). Adenosine deaminase polymorphism in man, Ann. Hum. Genet., 32, 9-14.

1310. Sperling O., Boer P., Eilam G., de Vries A. (1972). Evidence for molecular alteration of erythrocyte hypoxanthine-guanine phosphoribosyl transferase in a gouty family with partial deficiency of the enzyme, Rev. Eur. Etudes Clin. Biol., 17, 72-75.

1311. Spielberg S. P., Gordon G. B., Blake D. A., Goldstein D. A., Herlong H.F. (1981). Predisposition to phenytoin hepatotoxicity assessed in vitro, N. Engl. J. Med., 305, 722-727.

1312. Spranger J. (1972). The systemic mucopolysaccharidoses, Ergeb. Inn. Med. Kinderheilk [NF], 32, 165.

1313. Spranger J. (1983). The mucopolysaccharidoses. In: Emery A. E. H., Rimoin D. L. (eds.), Principles and Practice of Medical Genetics, Churchill Livingstone, Edinburgh, pp. 1339-1347.

1314. Spritz K. A., DeRiel J. K., Forget B. G., Weissman S. M. (1980). Complete nucleotide sequence of the human delta-globin gene, Cell, 21, 639-646.

1315. Suskind S. R., Yanofsky C., Bonner D. M. (1955). Allelic strains of neurospora lacking tryptophan synthetase: A preliminary immunochemical characterization, Proc. Natl. Acad. Sci. USA, 41, 577.

1316. Swift M., Chase Ch. (1979). Cancer in families with Xeroderma pigmentosum, J. Natl. Cancer Inst., 62, 1415-1421.

1317. Schmid C., Deininger P. L. (1975). Sequence organization of the human genome, Cell, 6, 345-358.

1318. Schnyder U. W (1976). Hereditare Epidermolyses Klassifikation, Erbprognose und Therapie, Fortschr. Prakt. Dermatol., 8, 1-8.

1319. Schroeder W. A., Huisman T. H. J. (1978). Human gamma chains: structural features. In: Stamatoyannopoulos G, Nienhuis A. (eds.), Cellular and molecular regulation of hemoglobin switching, Grune and Stratton, New York, pp. 29-45.

1320. Stamatoyannopoulos G. (1972). The molecular basis of hemoglobin disease, Ann. Rev. Genet., 6, 47.

1321. Stamatoyannopoulos G., Nienhuis A. W. (eds.) (1985). Experimental Approaches for the Study of Hemoglobin Switching, Alan. R. Liss, New York.

1322. Steinheider G., Melderis H., Ostertag W. (1975). Embryonic 8 chains of mice and rabbits, Nature, 275, 714-716.

1323. Stokes P. L., Asquith P., Cooke W.T. (1973). Genetics of coeliac disease, Clin. Gastroenterol., 2, 547-556.

1324. Studencki A. B., Conner B. J., Impraim C. C., Teplitz R. L., Wallace R.B. (1985). Discrimination among the human pA, ps and pc-globin genes using allelespecific oligonucleotide hybridization probes, Am. J. Hum. Genet., 37, 42-51.

1324a. Takizawa Т., Huang I.-Y, Jkuta Т., Yoshida A. (1986). Human glucose-6-phosphate dehydrogenase: primary structure and cDNA cloning, Proc. Natl. Acad. Sci. USA, in press.

1325. Taliaferro W. H., Huck J. G. (1923). The inheritance of sickle cell anaemia in man, Genetics, 8, 594.

1326. Tang B. K., Grant D. M., Kalow W. (1983). Isolation and identification of 5-acetyla-mino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man, Drug Metab. Dispos., 11, 218-220.

1327. Tarni S., Kono N., Nasu Т., Nishikawa M. (1969). Enzymatic basis for the coexistence of myopathy and hemolytic disease in inherited muscle phosphofructokinase deficiency, Biochem. Biophys. Res, Commun., 34, 77.

1328. Thalhammer O., Havelec L., Knoll E., Wehle E. (1977). Intellectual level (I. Q.) in heterozygotes for phenylketonuria (PKU), Hum. Genet., 38, 285-288.

1328a. TAem S. L., Wainscoat J. S., Lynch J. R., Weatherall D. J., Sampietro M., Fiorelli G. (1985). Direct detection of P. 39 thalassaemic mutation with Mae 1, Lancet, 1, 1095.

1329. Tilghman S. M., Tiemeyer D.C., Seirman J.G., Peterlin B. M., Sullivan M., Maizel J. V., Leder P. (1978). Intervening sequence of DNA identified in the structural portion of a mouse P-globin gene, Proc. Natl. Acad. Sci. USA, 75, 725-729.

1329a. Tonegawa S. (1983). Somatic generation of antibody diversity, Nature, 302, 575-581.

1330. Toniolo D., Persico M. G., Battistuzzi G., Luzzatto L. (1984). Partial purification and characterization of the messenger RNA for human glucose-6-phosphate dehydrogenase, Mol. Biol Med., 2, 89-103.

1331. Udenfriend S., Cooper J. R. (1952). The enzymatic conversion of phenylalanine to tyrosine, J. Biol. Chem., 194, 503.

1332. Utermann G., Langenbeck U., Beisiegel U., Weber W (1980). Genetics of the apolipoprotein E system in man, Amer. J. Hum. Genet., 31, 339-347.

1333. Valentine W. N., Fink K., Paglia D. E., Harris S. R., Adams W. S. (1974). Hereditary hemolytic anemia with human erythrocyte pyrimidine S' nucleotidase deficiency, J. Clin. Invest., 54, 866-879.

1334. Valentine W. N., Paglia D. E., Tartaglia A. P., Gilsanz F. (1977). Hereditary hemolytic anemia with increased adenosine triphosphate, Science, 195, 783-784.

1335. Vesell E. S. (1973). Advances in pharmacogenetics. In: ProG. Med. Genet., 9, 291-367.

1336. Vischer T. L. (1983). Pharmacogenetics in therapy with gold and other slowacting antirheumatic drugs, Rheumatology, 8, 220-228.

1337. Vogel F. (1959). Moderne Probleme der Humangenetik, Ergeb. Inn. Med. Kinderheilk, 12, 52-125.

1338. Vogel F. (1964). Eine vorlaufige Abschatzung der Anzahl manschlicher Gene, Z. Menschl. Vererbungs-Konstitutionslehre, 37, 291-299.

1339. Vogel F. (1964). Preliminary estimate of the number of human genes, Nature, 201, 847.

1340. Vogel F. (1984). Relevant deviations in hete-rozygotes of autosomal-recessive diseases, Clin. Genet, 25, 381-415.

1341. Wachtel S. S. (1977). H-Y antigen and the genetics of sex determination, Science, 198, 797-799.

1342. Wachtel S. (ed.) (1981). Errors of sex determination (Proc. of the Kroc. Foundation Conf.), Hum. Genet, 58, 1-127.

1343. Wachtel S. S., Ohno S., Loo G. C., Boyse E. A. (1975). Possible role of H-Y antigen in primary sex determination, Nature, 257, 235-236.

1344. Wainscoat J. S., Thein S. L., Higgs D. R., Bell J. I., Weatherall D. J., Al-Awamy В. H., Serjeant G. R. (1985). A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease, Br. J. Haematol., 60, 261-268.

l344a. Weinwright B. J. (et ей.) (1985). Localization of cystic fibrosis locus of human chromosome 7cen-p22, Nature, 318, 384-385.

1345. Waller H. D., Benohr A. Chr. (1976). Enzymdefekte in Glykolyse und Nucleotidstoffwechsel roter Blutzellen bei nichtspherocytaren hamolytischen Anamien, Klin. Wochenschr, 54, 803-850.

1346. Wang Т., Roden D. M., Wolfenden H. T., Woolsey R. L., Wood A. J. J., Wilkinson G. R. (1984). Influence of genetic polymorphism on the metabolism and disposition of encainide in man, J. Pharmacol. Exp. Therap, 228, 605-611.

1347. Watson J. D., Crick F. H. C. (1953). The structure of DNA, Cold Spring Harbor Symp. Quant. Biol, 18, 123-132.

1348. Weatherall D. J. (ed.) (1976). Hemoglobin: Structure, function and synthesis, Br. Med. Bull, 32, (3) 193-287.

1349. Weatherall D. J., Clegg J. B. (1976). Molecular genetics of human hemoglobin, Ann. Rev. Genet, 10, 157-178.

1350. Weatherall D. J., Clegg J. B. (1981). The thalassemia syndromes, 3rd ed, Blackwell, Oxford.

1351. Weatherall D. J., Wainscoat J. S., TheinS.L., Old J. M., Wood W. G., Higgs D. R., Clegg J. B. (1985). Genetic and molecular analysis of mild forms of homozygous P-thalassemia, Ann. NY Acad. Sci, 445, 68-80.

1352. Weatherall D. J., Wood W. G., Jones R. W, Clegg J. B. (1985). The developmental genetics of human hemoglobin. In: Experimental Approaches for the Study of Hemoglobin Switching, Stamatoyannopoulos G, Nienhuis A. W. (eds.), Alan R. Liss, New York, pp. 3-25.

1353. Wedlund P. J., Aslanian W. S., McAllister С. В., Wilkinson G. R., Branch R. A. (1984). Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism, Clin. Pharmacol. Therap, 36, 773-780.

1354. Weinshilboum R. M., Sladek S. L., (1980). Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity, Am. J. Hum. Genet, 32, 651-662.

1355. White J. M. (1974). The unstable hemoglobin disorders, Clin. Haematol, 3, 333-356.

1356. White J. M. (1976). The unstable hemoglobins, Br. Med. Bull, 32, 219-222.

1357. White J. M., Dacie J. V. (1971). The unstable hemoglobinsmolecular and clinical features, ProG. Hematol, 7, 69-109.

1357a. White R. et al. (1985). A closely linked genetic marker for cystic fibrosis, Nature, 318, 382-384.

1358. Wieacker P., Davies K., Pearson P., Ropers H. H. (1983). Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences, Lancet, 1, 1325-1326.

1359. Wilkins L. (1950). The diagnosis and treatment of endocrine disorders in childhood and adolescence, Thomas, Springfield.

1360. Williamson R. (1976). Direct measurement of the number of globin genes, Br. Med. Bull, 32, 246-250.

1361. Wilson J. M., Young А. В., Kelley W. N. (1983). Hypoxanthineguanine phosphoribosyltrans-pherase deficiency, N. Engl. Med, 309, 900-910.

1362. Wolf U., Engel W. (1972). Gene activation during early development of mammals, Hum. Genet, 15, 99-118.

1363. Wolfe L. C., John K. M., Falcone J. C., Byrne A. M., Lux S. E. (1982). A genetic defect in the binding of protein 4.1 to spectrin in a kindred with hereditary spherocytosis, N. Engl. J. Med, 307, 1367-1374.

1363a. Woo S. L. C., Guttler F., Ledley F. D., Lidsky A. S., Kwok S. С. М., Dilella A. G., Robson K. J. H. (1985). The human poenylalanine hydroxylase gene. In: (K. Berg, ed.) Medical genetics Past, present, future, New York, A.R. Liss, pp. 123-135.

1364. Wood W.G., Clegg J. В., Weatherall D. J. (1977). Developmental biology of human gemoglobins. In: Progress in hematology, Brown E. B. (ed.), Vol. X, Grune and Stratton, New York, pp. 43-90.

1365. Worthy т. е., Grobner W, Kelley W.N. (1974). Hereditary orotic aciduria: Evidence for a structural gene mutation, Proc. Natl. Acad. Sci. USA, 71, 3031-3035.

1366. Yoshida A. (1968). Subunit structure of human glucose-6-phosphate dehydrogenase, Biochem. Genet, 2, 237.

1367. Yoshida A. (1982). Molecular basis of difference in alcohol metabolism between Orientals and Caucasians, Jpn. Hum. Genet., 27, 55-70.

1368. Yoshida A., Beutler E. (1983). G-6-PD variants: another up-date, Ann. Hum. Genet., 47, 25-38.

1369. Van Zeeland A. A., Van Diggelen M. C. E., Simons J. W. I. M. (1972). The role of metabolic cooperation in selection of hypoxanthine guanine phosphoribosyl transferase (HGPRT) deficient mutants from diploid mammalian cell strains, Mutation Res., 14, 355-363.

1370. ZenzesM. Т., Wolf U., Gunther E., Engel W. (1978). Studies of the function of H-Y antigen: dissociation and reorganization experiments on rat gonadal tissue, Cytogenet. Cell Genet., 20, 365-372.

1371. Zimmermann U., Riemann F., Pilwat G. (1976). Enzyme loading of electrically homogeneous human red blood cell ghosts by dielectric breakdown, Biochim. Biophys. Acta, 436, 460-474.